Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy.


Journal

Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 06 11 2021
accepted: 22 03 2022
pubmed: 24 4 2022
medline: 25 2 2023
entrez: 23 4 2022
Statut: ppublish

Résumé

The objective of the study was to test the impact of implementing standard full functional-length urethral sphincter (FFLU) and neurovascular bundle preservation (NVBP) with intraoperative frozen section technique (IFT) on long-term urinary continence in patients undergoing robotic-assisted radical prostatectomy (RARP). We relied on an institutional tertiary-care database to identify patients who underwent RARP between 01/2014 and 09/2019. Until 10/2017, FFLU was not performed and decision for NVBP was taken without IFT. From 11/2017, FFLU and IFT-guided NVBP was routinely performed in all patients undergoing RARP. Long-term continence (≥ 12 months) was defined as the usage of no or one safety- pad. Uni- and multivariable logistic regression models tested the correlation between surgical approach (standard vs FFLU + NVBP) and long-term continence. Covariates consisted of age, body mass index, prostate volume and extraprostatic extension of tumor. The study cohort consisted of 142 patients, with equally sized groups for standard vs FFLU + NVBP RARP (68 vs 74 patients). Routine FFLU + NVBP implementation resulted in a long-term continence rate of 91%, compared to 63% in standard RARP (p < 0.001). Following FFLU + NVBP RARP, 5% needed 1-2, 4% 3-5 pads/24 h and no patient (0%) suffered severe long-term incontinence (> 5 pads/24 h). No significant differences in patient or tumor characteristics were recorded between both groups. In multivariable logistic regression models, FFLU + NVBP was a robust predictor for continence (Odds ratio [OR]: 7.62; 95% CI 2.51-27.36; p < 0.001). Implementation of FFLU and NVBP in patients undergoing RARP results in improved long-term continence rates of 91%.

Identifiants

pubmed: 35459985
doi: 10.1007/s11701-022-01408-7
pii: 10.1007/s11701-022-01408-7
pmc: PMC9939484
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

177-184

Informations de copyright

© 2022. The Author(s).

Références

Haese A, Knipper S, Isbarn H, Heinzer H, Tilki D, Salomon G et al (2019) A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both procedures. BJU Int 123(6):1031–1040
doi: 10.1111/bju.14760 pubmed: 30927303
Pompe RS, Tian Z, Preisser F, Tennstedt P, Beyer B, Michl U et al (2017) Short- and long-term functional outcomes and quality of life after radical prostatectomy: patient-reported outcomes from a tertiary high-volume center. Eur Urol Focus 3(6):615–620
doi: 10.1016/j.euf.2017.08.001 pubmed: 28869202
Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375(15):1415–1424
doi: 10.1056/NEJMoa1606220 pubmed: 27626136
Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367(3):203–213
doi: 10.1056/NEJMoa1113162 pubmed: 22808955 pmcid: 3429335
Hoeh B, Preisser F, Wenzel M, Humke C, Wittler C, Köllermann J et al (2021) Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltration. Urol Oncol: Semin Orig Investig. https://doi.org/10.1016/j.urolonc.2021.07.028
doi: 10.1016/j.urolonc.2021.07.028
Whiting PF, Moore THM, Jameson CM, Davies P, Rowlands M-A, Burke M et al (2016) Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review. BJU Int 118(2):193–204
doi: 10.1111/bju.13499 pubmed: 27087414
Borges RC, Tobias-Machado M, Gabriotti EN, Dos Santos Figueiredo FW, Bezerra CA, Glina S (2019) Post-radical prostatectomy urinary incontinence: is there any discrepancy between medical reports and patients’ perceptions? BMC Urol 19(1):32
doi: 10.1186/s12894-019-0464-6 pubmed: 31060521 pmcid: 6501406
Ilie G, White J, Mason R, Rendon R, Bailly G, Lawen J et al (2020) Current mental distress among men with a history of radical prostatectomy and related adverse correlates. Am J Mens Health 14(5):155798832095753
doi: 10.1177/1557988320957535
Novara G, Ficarra V, D’Elia C, Secco S, Cavalleri S, Artibani W (2011) Trifecta outcomes after robot-assisted laparoscopic radical prostatectomy: trifecta outcomes after RALP. BJU Int 107(1):100–104
doi: 10.1111/j.1464-410X.2010.09505.x pubmed: 20633003
Schlomm T, Heinzer H, Steuber T, Salomon G, Engel O, Michl U et al (2011) Full functional-length urethral sphincter preservation during radical prostatectomy. Eur Urol 60(2):320–329
doi: 10.1016/j.eururo.2011.02.040 pubmed: 21458913
Steiner MS (1994) The puboprostatic ligament and the maleurethral suspensory mechanism: an anatomic study. Urology 44(4):530–534
doi: 10.1016/S0090-4295(94)80052-9 pubmed: 7941191
Majoros A, Bach D, Keszthelyi A, Hamvas A, Mayer P, Riesz P et al (2007) Analysis of risk factors for urinary incontinence after radical prostatectomy. Urol Int 78(3):202–207
doi: 10.1159/000099338 pubmed: 17406127
Hammerer P, Huland H (1997) Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy. J Urol 157(1):233–236
doi: 10.1016/S0022-5347(01)65334-5 pubmed: 8976260
Doudt AD, Zuckerman JM (2018) Male slings for post-prostatectomy incontinence. Rev Urol 20(4):158–169
pubmed: 30787674 pmcid: 6375003
Kim M, Park M, Pak S, Choi S-K, Shim M, Song C et al (2019) Integrity of the urethral sphincter complex, nerve-sparing, and long-term continence status after robotic-assisted radical prostatectomy. Eur Urol Focus 5(5):823–830
doi: 10.1016/j.euf.2018.04.021 pubmed: 29759661
Preisser F, Theissen L, Wild P, Bartelt K, Kluth L, Köllermann J et al (2019) Implementation of intraoperative frozen section during radical prostatectomy: short-term results from a German tertiary-care center. Eur Urol Focus. https://doi.org/10.1016/j.euf.2019.03.007
doi: 10.1016/j.euf.2019.03.007 pubmed: 31296485
Theissen L, Preisser F, Wenzel M, Humke C, Roos FC, Kluth LA et al (2019) Very early continence after radical prostatectomy and its influencing factors. Front Surg 6:60
doi: 10.3389/fsurg.2019.00060 pubmed: 31709260 pmcid: 6823177
Preisser F, Cooperberg MR, Crook J, Feng F, Graefen M, Karakiewicz PI et al (2020) Intermediate-risk prostate cancer: stratification and management. Eur Urol Oncol 3(3):270–280
doi: 10.1016/j.euo.2020.03.002 pubmed: 32303478
Kattan MW, Wheeler TM, Scardino PT (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17(5):1499–1507
doi: 10.1200/JCO.1999.17.5.1499 pubmed: 10334537
Steuber T, Graefen M, Haese A, Erbersdobler A, Chun FK-H, Schlom T et al (2006) Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 175(3 Pt 1):939–944
doi: 10.1016/S0022-5347(05)00342-3 pubmed: 16469587
Beyer B, Schlomm T, Tennstedt P, Boehm K, Adam M, Schiffmann J et al (2014) A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomy. Eur Urol 66(1):138–144
doi: 10.1016/j.eururo.2013.12.014 pubmed: 24411279
Hoeh B, Preisser F, Wenzel M, Humke C, Wittler C, Hohenhorst JL et al (2021) Correlation of urine loss after catheter removal and early continence in men undergoing radical prostatectomy. Curr Oncol 28(6):4738–4747
doi: 10.3390/curroncol28060399 pubmed: 34898569 pmcid: 8628712
Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B et al (2010) A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol 57(2):179–192
doi: 10.1016/j.eururo.2009.11.009 pubmed: 19931974
Walz J, Epstein JI, Ganzer R, Graefen M, Guazzoni G, Kaouk J et al (2016) A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimisation of cancer control and preservation of continence and erection in candidates for radical prostatectomy: an update. Eur Urol 70(2):301–311
doi: 10.1016/j.eururo.2016.01.026 pubmed: 26850969
Lee SE, Byun S-S, Lee HJ, Song SH, Chang IH, Kim YJ et al (2006) Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy. Urology 68(1):137–141
doi: 10.1016/j.urology.2006.01.021 pubmed: 16777192
Paparel P, Akin O, Sandhu JS, Otero JR, Serio AM, Scardino PT et al (2009) Recovery of urinary continence after radical prostatectomy: association with urethral length and urethral fibrosis measured by preoperative and postoperative endorectal magnetic resonance imaging. Eur Urol 55(3):629–639
doi: 10.1016/j.eururo.2008.08.057 pubmed: 18801612
Wenzel M, Preisser F, Mueller M, Theissen LH, Welte MN, Hoeh B et al (2021) Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy. Int Urol Nephrol 53(7):1297–1303
doi: 10.1007/s11255-021-02809-7 pubmed: 33606155 pmcid: 8192356
Reeves F, Preece P, Kapoor J, Everaerts W, Murphy DG, Corcoran NM et al (2015) Preservation of the neurovascular bundles is associated with improved time to continence after radical prostatectomy but not long-term continence rates: results of a systematic review and meta-analysis. Eur Urol 68(4):692–704
doi: 10.1016/j.eururo.2014.10.020 pubmed: 25454614
Michl U, Tennstedt P, Feldmeier L, Mandel P, Oh SJ, Ahyai S et al (2016) Nerve-sparing surgery technique, not the preservation of the neurovascular bundles, leads to improved long-term continence rates after radical prostatectomy. Eur Urol 69(4):584–589
doi: 10.1016/j.eururo.2015.07.037 pubmed: 26277303
Barakat B, Othman H, Gauger U, Wolff I, Hadaschik B, Rehme C (2021) Retzius sparing radical prostatectomy versus robot-assisted radical prostatectomy: which technique is more beneficial for prostate cancer patients (MASTER Study)? A systematic review and meta-analysis. Eur Urol Focus. https://doi.org/10.1016/j.euf.2021.08.003
doi: 10.1016/j.euf.2021.08.003 pubmed: 34933832
Hoeh B, Wenzel M, Hohenhorst L, Köllermann J, Graefen M, Haese A et al (2022) Anatomical fundamentals and current surgical knowledge of prostate anatomy related to functional and oncological outcomes for robotic-assisted radical prostatectomy. Front Surg. 8:825183
doi: 10.3389/fsurg.2021.825183 pubmed: 35273992 pmcid: 8901727
Schlomm T, Tennstedt P, Huxhold C, Steuber T, Salomon G, Michl U et al (2012) Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients. Eur Urol 62(2):333–340
doi: 10.1016/j.eururo.2012.04.057 pubmed: 22591631

Auteurs

Benedikt Hoeh (B)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. benedikt.hoeh@kgu.de.
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada. benedikt.hoeh@kgu.de.

Jan L Hohenhorst (JL)

Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Mike Wenzel (M)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Clara Humke (C)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Felix Preisser (F)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Clarissa Wittler (C)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Marie Brand (M)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Jens Köllermann (J)

Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Thomas Steuber (T)

Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Markus Graefen (M)

Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Derya Tilki (D)

Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Department of Urology, Koc University Hospital, Istanbul, Turkey.

Pierre I Karakiewicz (PI)

Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.

Andreas Becker (A)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Luis A Kluth (LA)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Felix K H Chun (FKH)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Philipp Mandel (P)

Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH